(Q48272507)

10 February 2018

title

Investigating the role of IL-33 in the pathogenesis of Behçet's Disease. (English)

1 reference

10 February 2018

0 references

Pamir Çerçi

1

0 references

author name string

Seda Altıner

2

1 reference

10 February 2018

Ali İnal

3

1 reference

10 February 2018

Kenan Köse

4

1 reference

10 February 2018

Göksal Keskin

5

1 reference

10 February 2018

Ümit Ölmez

6

1 reference

10 February 2018

publication date

17 April 2017

1 reference

10 February 2018

published in

Acta Clinica Belgica

1 reference

10 February 2018

volume

72

1 reference

10 February 2018

issue

6

1 reference

10 February 2018

page(s)

434-438

1 reference

10 February 2018

Behcet's Disease: Is There Geographical Variation? A Review Far from the Silk Road

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Disease-associated functions of IL-33: the new kid in the IL-1 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Elevated serum level of IL-33 and sST2 in patients with ankylosing spondylitis: associated with disease activity and vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Involvement of IL-33 in the pathogenesis of rheumatoid arthritis: the effect of etanercept on the serum levels of IL-33.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Interleukin-1-related genes polymorphisms in Turkish patients with Behçet disease: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Potential Therapeutic Aspects of Alarmin Cytokine Interleukin 33 or Its Inhibitors in Various Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Current concepts in the etiology and treatment of Behçet disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

IL-33 and IL-33 receptors in host defense and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Increased interleukin 33 in patients with neuro-Behcet's disease: correlation with MCP-1 and IP-10 chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Distinct serum and synovial fluid interleukin (IL)-33 levels in rheumatoid arthritis, psoriatic arthritis and osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

Targeting IL-33 in autoimmunity and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

IL-33 in rheumatoid arthritis: potential role in pathogenesis and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

IL-33: a potential therapeutic target in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17843286.2017.1314241

10.1080/17843286.2017.1314241

21 January 2018

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

28412856

1 reference

10 February 2018